Human rabies post exposure prophylaxis in Bhutan, 2005-2008: Trends and risk factors. by Tenzin et al.
1 
 
This is a pre-copyedited, author-produced PDF of an article published in [Vaccine] following peer review. The 
definitive publisher-authenticated version [Tenzin, Dhand, N. K., & Ward, M. P. (2011). Human rabies post 
exposure prophylaxis in Bhutan, 2005-2008: Trends and risk factors. Vaccine, 29, 4094 – 4101] is available online 
at http://www.sciencedirect.com/science/article/pii/S0264410X11005093  (paywalled) 
 
 
Human rabies post exposure prophylaxis in Bhutan, 2005–2008: 
Trends and risk factors 
 
Tenzin1,2, Navneet K Dhand1 and Michael P Ward1 
 
1 The Faculty of Veterinary Science, The University of Sydney, Camden, NSW2570, Australia 
2 Regional Livestock Development Centre, Gelephu, Bhutan 
 
 
Vaccine, 29: 4094–4101 
Available online at: http://www.sciencedirect.com/science/article/pii/S0264410X11005093 (paywalled) 
 
 
Abstract 
 
The aim of this study was to understand the use and distribution of human rabies post exposure 
prophylaxis (PEP) vaccine in Bhutan and to identify risk factors for receiving an incomplete course of the 
vaccine. We analysed post exposure treatment records from 28 medical hospitals from 2005 to 2008. 
Males (59%) accounted for significantly more PEP events than females (41%) across all age groups (P < 
0.001). Children–particularly 5–9 years of age – received more rabies PEP than other age groups. Animal 
bite and non-bite accounted for 27% (n = 2239) and 16% (n = 1303) of rabies PEP, respectively, whilst 
57% (n = 4773) of the PEP events had no recorded information about the reasons for post exposure 
treatment. Post exposure treatment was provided throughout the year with a higher number during the 
winter and spring months. The number of PEP events significantly (P < 0.001) increased between 2005 
and 2008, from <1000 to >2800 events, respectively. Significantly (P < 0.001) more PEP events were 
reported from the southern parts of Bhutan that are endemic for rabies or those areas in eastern 
Bhutan that have reported rabies outbreaks than other parts of Bhutan. Forty percent (n = 3360) of the 
patients received an incomplete course of vaccine (<5-doses of vaccine intramuscular). Results suggest 
that patients with animal bite injury were less likely to receive an incomplete vaccine course than non-
bite recipients, and patients presented to hospitals in rabies endemic or outbreak areas were less likely 
to receive an incomplete course than in non-rabies areas or rabies free areas. Similarly, patients 
presenting to hospitals for PEP during spring and summers months were less likely to receive an 
incomplete vaccine course than those during other seasons. Public education campaigns need to be 
conducted in Bhutan to reduce dog bite incidents and also to prevent mass exposures to rabies. A 
thorough assessment of each individual case based on the WHO guidelines would reduce unnecessary 
PEP (and therefore costs) in Bhutan. 
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1. Introduction 
 
Rabies remains a significant public health problem in the world, with an estimated 55 000 human deaths 
occurring each year, mainly in developing countries of Asia and Africa (Knobel et al., 2005). Although 
rabies is inevitably fatal once clinical symptoms develop, the disease is preventable with timely 
treatment following an exposure to a rabid animal. The recommended post-exposure treatment consists 
of a thorough washing or flushing of the bite wound with soap and water or with viricidal agents, 
administration of rabies vaccine and infiltration of rabies immunoglobulin into and around the bite 
wound (WHO, 1996; WHO, 2010a). The main aim of post exposure prophylaxis (PEP) is to neutralize or 
inactivate inoculated virus in the wound before it can enter the nervous system of the patient (Warrel 
2004). Therefore, a quick decision – based on a thorough assessment of the risk – must be made by the 
physician about whether to initiate rabies PEP. Post exposure prophylaxis is unnecessary and is a waste 
of resources if the biting animal is not rabid. As per the recent estimates of the World Health 
Organization (WHO), ≥15 million people receive PEP for rabies worldwide each year, mostly in India and 
China (WHO, 2010a). Children are at the greatest risk of rabies exposures and approximately 40% of PEP 
is given to children aged 5–14 years old (WHO, 2010a). 
 
In Bhutan, rabies in animals is mainly prevalent in the southern districts that border India. Between 1996 
and 2009, 814 cases of rabies were reported in dogs and other domestic animals in Bhutan (Tenzin et al., 
2011). Similarly, from January 2006 to January 2011, nine human rabies deaths have been reported 
(eight cases in southern Bhutan and one in eastern Bhutan, 1.2/100000 population at-risk) (MoH, 2010; 
Kuensel 2009a; Kuensel 2010a; BBS, 2011). Because of the frequent outbreaks of rabies in dogs and farm 
animals in southern Bhutan, medical hospitals in all regions provide rabies PEP free of charge to those 
who have been bitten by animals (category II and III exposure) and also for category I exposure 
(touching/feeding animals, licks on intact skin) or for ingestion of meat and dairy products derived from 
suspected rabid animals. Currently, the human diploid cell vaccine (HDCV) is used and treatment follows 
the standard 5-dose (1 ml each) intramuscular administration regimen (Essen regimen) on days 0, 3, 7, 
14 and 28 (WHO, 2010a). Although the number of human rabies cases in Bhutan is low and sporadic, the 
number of persons seeking rabies PEP is increasing because of the large number of stray and free-
roaming dogs and increased incidents of dog bite, and because of mass exposures (likely category I 
exposure) during periods of rabies outbreaks in animals (BBS, 2010, Bhutan Observer 2010; Kuensel 
2009b). However, little is known about the epidemiologic characteristics of rabies PEP use in Bhutan. 
 
In this study, we explored the epidemiology of human rabies PEP use based on treatment records 
between January 2005 and December 2008 from 28 selected hospitals and Basic Health Units, in Bhutan. 
The aim of this study was to describe the use and distribution of human rabies post exposure 
prophylaxis in Bhutan and to identify risk factors for an incomplete course of PEP. The results from this 
report are intended to assist medical practitioners and public health policy makers to reduce the 
incidences of human exposures and prioritizing the use of PEP based on the WHO guidelines. This is also 
likely to improve the national surveillance for rabies post exposure prophylaxis in Bhutan. 
 
2. Materials and methods 
 
2.1. Data sources 
 
Bhutan is administratively divided into 20 districts and 205 subdistricts and has a population of about 
0.68 million (NSB, 2005). There are 30 medical hospitals, 181 Basic Health Units (BHUs) and 38 
indigenous medicine units, distributed in the districts and sub-districts in the country (MoH, 2010). 
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Human animal bites are not a reportable condition in Bhutan, but bite victims visit hospitals for 
treatment and medical advice. Post exposure rabies prophylaxis vaccine is mainly provided via hospitals, 
but is also given at some of the BHUs located in rabies endemic areas or during rabies outbreaks. These 
hospitals and BHUs record basic information about patients provided with post exposure prophylaxis. 
For our analysis, we acquired PEP case data from 18 hospitals and 10 BHUs in Bhutan for the period 
January 2005 to December 2008. There was no PEP record (no data) in five of the civilian hospitals 
contacted. The PEP data from the remaining seven hospitals were not included due to logistic reasons of 
data collection (five military hospitals and two civilian hospitals). Similarly, majority of the BHUs were 
not considered for data collection due to logistic reason (remote location and also absence of rabies 
cases in those areas, assuming no PEP course would have been given). Only sampled BHUs from rabies 
endemic/outbreak areas were included for our analysis. There was no reporting system of PEP data 
(especially individual case) to the main data management unit in the Health Ministry in Bhutan from the 
respective health centers and was difficult to access this information. Available information that we 
collected included demographic data (age and gender of victims), mode of contact and circumstances of 
exposure, date of patient presentation to the hospital or BHU and date of administration of PEP. The 
study was approved by the Ethics Committee of the Human Research and Epidemiology Unit, Ministry of 
Health, Bhutan. 
 
2.2. Data analysis 
 
The data were entered into a Microsoft Excel spreadsheet (Microsoft Excel, Redmond, WA). Descriptive 
analyses of the data were performed using Microsoft Excel. Chi-square tests were used to compare the 
difference in proportions of PEP recipients between gender, age groups, season and years. To make 
meaningful comparisons between age groups, observed frequencies of PEP for various age groups were 
compared with expected frequencies calculated from the Bhutan census data of 2005 (NSB, 2005). For 
comparing gender, seasonal and annual differences, equal expected frequencies were assumed 
between groups. A P-value of <0.05 was considered statistically significant.  
 
Although the complete course schedule of post exposure prophylaxis (Essen regimen) is five doses 
(WHO, 2010a), many patients received an incomplete course of the vaccine (i.e. <5 doses). We 
conducted logistic regression analyses (GenStat Version 11.1 (VSN International Ltd., UK) to identify 
possible risk factors for incomplete PEP as the outcome variable (incomplete versus complete). The risk 
factors investigated included age group, gender, type of exposure (animal bite versus non-bite), rabies 
risk area (rabies outbreak or endemic area versus non-outbreak or free areas), season and year. Initially, 
we constructed contingency tables between explanatory variables and the outcome, calculated 
unadjusted odds ratios (OR) and the corresponding 95% confidence intervals and P-values. The variables 
that had a significant crude association with the outcome (P < 0.25) were selected for multivariable 
logistic regression model, using a forward stepwise selection approach. The selected variables were 
examined for collinearity in pairs by calculating Spearman’s rank correlation coefficient (ρ) and no highly 
correlated pairs of variables (ρ > |0.70|) were observed and all variables were retained for further 
analysis. Variables with P-values <0.05 (based on the likelihood-ratio chi-squared test) in the 
multivariable model were considered to be significantly associated with incomplete PEP. Model 
diagnostics were checked by examining the standardised Pearson residuals, leverage values, and delta 
betas (Dohoo et al., 2009). To control for effects of clustering of observations from the same hospitals 
(and BHUs), we refitted the final model using a generalized linear mixed model by adding hospitals as a 
random effect term. Intra-class correlation (ICC) was calculated for the random effect term using the 
latent variable approach (Dohoo et al., 2009). 
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A Geographic Information System (ArcGIS 9.3, ESRI, Redland, CA, USA) was used to illustrate the 
distributions of human rabies post exposure prophylaxis given in different hospitals and BHUs in Bhutan. 
Here, the total number of patients that were given PEP in each selected hospital/BHU was mapped and 
represented by proportional symbols for visualization and for understanding the geographic distribution 
of PEP. 
 
3. Results 
 
Data were collected from a total of 9084 patients from 18 hospitals and 10 Basic Health Units in Bhutan. 
Data for pre exposure prophylaxis (117 cases) were excluded from the analysis because the aim of the 
study was to understand the use and distribution of post exposure prophylaxis only. Of the 8967 PEP 
events, 8315 (92.7%) patients were given various courses of rabies post exposure prophylaxis, 504 
patients were given tetanus toxoid injection, and there was no information about the type of treatment 
provided in the remaining 148 patients. Thus for the analyses reported in this paper, we used a dataset 
of 8315 patients that were given PEP.  
 
3.1. Gender  
 
A total of 8302 patients (99.8%) had complete information for gender. Of these, 58.6% (n = 4864) were 
male and 41.4% (n = 3438) female. The proportion of rabies PEP recipients was significantly higher in 
males than females during the study period (χ2 = 277; P < 0.001). 
 
3.2. Age 
 
Of the 8315 patients that received PEP, age was not recorded for 208 patients. The median age of 
patients receiving PEP was 21 years (range <1 to 96 years) and the modal age was 8 years. The observed 
and the expected frequencies of PEP recipients differed significantly across age groups (χ2= 320; P < 
0.001). The majority (n = 5438, 67.8%) of the patients that received PEP were below 30 years of age, and 
the maximum number of cases was observed in the 5–9 years (n = 1235; 15.2%) and then the 10–14 
years (n = 1049; 12.9%) age groups. Figure 1 illustrates the distribution of rabies PEP by age and gender 
between 2005 and 2008 in Bhutan, in which the proportion of PEP recipients in males was significantly 
higher than females across all age groups. 
 
3.3. Seasonal and annual trend of post exposure prophylaxis 
 
Data on date of PEP administration were available for 8187 patients. The first date (day 0) of the 5-dose 
vaccine course was used to examine the seasonal pattern. Post exposure prophylaxis were given 
throughout the year, but more were provided during the winter (n = 2367; 28.9%) and spring (n = 2256, 
27.6%) months (Figure 2). The overall proportion of vaccine recipients across seasons was significantly 
different (χ2 = 156; P < 0.001). The proportion of PEP across each season in each year was also 
significantly different compared to that expected (P < 0.001). The number of patients that received PEP 
increased from <1000 patients in 2005 to >2800 patients in 2008 (χ2 = 1059; P < 0.001). 
 
3.4. Mode of contact and type of exposures 
 
Both animal bite and non-bite incidents were presented to the hospitals and BHUs for post exposure 
prophylaxis. The majority (n = 4773; 57.4%) of the PEP case records did not have information about the 
reasons for PEP (data not recorded in the treatment register); 26.9% (n = 2239) were given PEP because 
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of animal bites and 15.7% (n = 1303) for non-bite incidents. The non-bite incidents mainly included 
category I exposure (touching and feeding of animals) and also ingestion of meat and dairy products 
derived from rabid animals. The details of the various reasons for PEP are illustrated in Table 1. 
 
 
 
Figure 1: Distribution of rabies post exposure prophylaxis in people by age and gender in Bhutan from 
2005 to 2008. 
 
 
 
Figure 2: Monthly pattern of human rabies post exposure prophylaxis in Bhutan, 2005–2008. 
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Table 1: Descriptive statistics for mode of (likely) exposure and reasons for receiving rabies post 
exposure prophylaxis by people in Bhutan for a study period 2005 to 2008.  
 
Reasons for PEP rabies vaccination 
Number of PEP 
rabies vaccine 
given 
% of PEP 
given 
Dog bite 2099 25.24 
Cat bite 71 0.85 
Cat scratches 16 0.19 
Rat bite 43 0.52 
Other animal bite (monkey, bear, horse, goat, pig) 10 0.12 
Contact with rabies patient 135 1.62 
Contact/handled rabid cattle (feeding, touching and  
handling of carcasses during zoo sanitary measures) 234 2.81 
Contact/handled rabid dog (during zoosanitary 
measures)  142 1.71 
Dairy product consumption (milk, butter, cheese) 
derived from rabid or rabies suspected cow 607 7.30 
Meat consumption (meat derived from rabid or rabies 
suspected cattle) 156 1.88 
Other mode of contacts 29 0.35 
Missing information  4773 57.40 
Total 8315 100 
 
3.5. Patterns of post exposure prophylaxis due to dog bites 
 
Of the animal bite incidents, dog bites formed a major (93.7%) component of PEP in humans. Of the 
2099 dog bite incidents in humans, 59.4% (n = 1243) of patients were male and 40.6% (n = 849) female, 
and the difference between the gender was significant (χ2 = 74.20; P < 0.001). The majority of the PEP 
due to dog bite was reported in children, especially within the age group of 5–14 years. The proportions 
of observed and expected PEP in humans due to dog bite were significantly different across age groups 
(χ2 = 98.44; P < 0.001). Figure 3 illustrates the age and sex distribution of PEP due to dog bites. It 
indicates that males received more PEP than females across all age groups due to dog bites in Bhutan. 
Dog bites were reported throughout the year, but more were reported in the spring months. The 
difference between the observed and expected cases was significant across all seasons (χ2 = 22.17; P < 
0.001). 
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Figure 3: Distribution of dog bite victims classified by age and gender who received rabies post exposure 
prophylaxis in Bhutan, 2005–2008. 
 
3.6. Rabies post exposure prophylaxis course 
 
Of the patients receiving rabies PEP, 3859 (46.4%) received the standard 5-dose intramuscular injection 
(Essen regimen) on day 0, 3, 7, 14 and 28; 1096 (13.2%) patients received a 6-dose course (including day 
90); 705 (8.5%) patients received a 4-dose course; 1337 (16.1%) patients received a 3-dose course; 551 
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Overall, 3360 (40.4%) patients received an incomplete course of the vaccine (<5-dose course) based on 
the Essen regimen. Of the 3360 incomplete vaccine course recipients, 18.8% (n = 631) of the patients 
had animal bite injuries, 15.5% (n = 520) of the patients had non-bite incidents, and there was no 
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3.6.1. Risk factors for incomplete PEP course 
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and the gender, all other variables were included in the multivariable model. Patients that presented to 
hospitals in rabies endemic or rabies outbreak areas were more likely to complete the vaccine course 
than patients in non-rabies risk areas. Compared to 0–14 years, other age groups were more likely to 
have an incomplete vaccine course; patients that visited a hospital for PEP during winter and autumn 
months were more likely to have an incomplete vaccine course than in spring and summer months. The 
proportion of incomplete course of vaccine recipients significantly increased over the study years (2006 
through 2008). Table 3 illustrates the final generalized linear mixed model in which the hospital was 
included as a random effect in the model. Coefficients for all variables were almost similar to that of the 
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unadjusted multivariable model except for area (rabies outbreak or endemic area versus non-outbreak 
or free areas) which became non-significant in the model adjusted for clustering. The estimated intra-
class correlation (ICC) in the final model was 0.63, indicating that a greater proportion of total variation 
was clustered at the hospital level. Examination of the residuals showed no evidence of unusual 
influence of any observation on the model predictions. 
 
3.7. Spatial distribution of post exposure prophylaxis 
 
The distribution of the total number of patients given rabies PEP in different hospitals (and BHUs) in 
Bhutan is shown in Figure 4. The map illustrates an unequal distribution of PEP patients among the 
hospitals. As expected, hospitals located in areas of southern Bhutan that are endemic for rabies and 
those hospitals with catchment areas covering reported rabies outbreaks during the study period (e.g. 
eastern Bhutan) had given significantly more (χ2 = 1847, P < 0.001) PEP (n = 6117, 73.57%) compared to 
hospitals located in the interior of Bhutan that did not report rabies (n = 2198, 26.43%). Within the 
interior parts of Bhutan, some of the hospitals located in western Bhutan (e.g. Thimphu and Paro) that 
have no history of presence of rabies for at least 18 years had provided a large number of rabies PEP to 
patients (see Figure 4). 
 
Table 2: Contingency table for explanatory variables with incomplete rabies post-exposure prophylaxis 
in Bhutan, 2005 to 2008, and odd ratios based on univariable logistic regression analysis. 
 
Variables/categories Incomplete Complete OR 95% CI P-valuea 
Age group     <0.001 
     0–14 1012 1893 1.00 -  
     15–29 1095 1438 1.42 1.27–1.59  
     30–44 609 918 1.30 1.14–1.47  
     > 45 456 686 1.23 1.07–1.41  
Gender     0.499 
     Female 1403 2035 1.00 -  
     Male 1949 2915 0.97 0.88–1.06  
Type of (likely) exposure 
(animal bite vs. non bite)     <0.001 
      No 520 631 1.00 -  
     Yes 783 1608 0.59 0.51–0.68  
Rabies outbreak/risk 
areas     <0.001 
     No 1452 1908 1.00 -  
     Yes 746 4209 0.23 0.21–0.26  
Season of PEP      <0.001 
     Winter (Dec–Feb) 1041 1326 1.00 -  
     Spring (Mar–May) 865 1391 0.79 0.67–0.91  
     Summer (Jun–Aug) 637 1273 0.63 0.51–0.76  
     Autumn (Sep–Nov) 762 892 1.08 0.96–1.21  
Year     <0.001 
     2005 238 641 1.00  -   
     2006 846 1206 1.88 1.59–2.24  
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     2007 1139 1623 1.89 1.59–2.23  
     2008 1137 1485 2.06 1.74–2.44  
a P-value based on likelihood ratio chi-square test of significance. 
 
Table 3: Final generalized linear mixed logistic model with hospitals added as random effect for 
incomplete rabies post exposure prophylaxis course in Bhutan for the study period 2005 to 2008 
 
Variables/categories b s.e (b) OR 95% CI P-value a 
Hospital-level random effect 5.78 2.45 - - - 
Constant 0.17 1.02 - - - 
Age group      
     0–14 - - 1.00  -  
     15–29 0.24 0.06 1.27 1.12–1.44 <0.001 
     30–44 0.26 0.07 1.29 1.11–1.49  
     > 45 0.20 0.08 1.22 1.04–1.43  
Rabies outbreak/risk areas      0.287 
     No - - 1.00 -  
     Yes -1.26 1.18 0.28 0.03–2.89  
Season of PEP      <0.001 
     Winter (Dec-Feb) - - 1.00 -  
     Spring (Mar-May) -0.24 0.07 0.78 0.67–0.90  
     Summer (Jun-Aug) -0.39 0.07 0.67 0.57–0.78  
     Autumn (Sep-Nov)  0.06 0.07 1.06 0.91–1.23  
Year     <0.001 
     2005 - - 1.00 -  
     2006 0.30 0.11 1.35 1.08–1.69  
     2007 0.32 0.10 1.37 1.12–1.69  
     2008 0.23 1.02 1.96 1.59–2.42  
a P-value based on likelihood ratio χ2 test of significance. 
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Figure 4: A district map of Bhutan showing the total number of persons (shown as proportional symbol) 
that were given rabies post exposure prophylaxis in different hospitals between 2005 and 2008.  
 
4. Discussion 
 
This report describes human rabies exposure and post exposure prophylaxis in Bhutan from 2005 to 
2008. Our study showed that the overall prevalence of PEP was higher for children, especially for those 
up to 14 years of age, and then the trend decreased as age increased (Figure 1). This is in agreement 
with several other studies (WHO, 2010a; Martin et al., 1969; Helmick 1983; Pancharoen et al., 2001; 
Sriaroon et al., 2006, Blanton et al., 2005; Edison et al., 2010; Wyatt et al., 1999). It has also been 
suggested that animal bites in children are more likely to be reported to hospitals for wound treatment 
and possible vaccination because of parental concern (Martin et al., 1969). However, rabies experts 
from the Asian countries believe that children are at high risk of exposure to rabies, but less likely to 
report animal exposure, such as scratches or licks from dogs and cats, to their parents (Dodet, 2010). In 
this study, dog bite incidents were also more common in children than adults (Figure 9.3) suggesting 
that children received higher PEP than adults. We also identified that dog bites and PEP are significantly 
greater in males than females across all age groups (Figures 2 and 3), a finding observed in other studies 
(Martin et al., 1969; Helmick 1983; Wyatt et al., 1999; Khokhar et al., 2003; O’Bell et al., 2006)  
 
Post exposure treatment was provided throughout the year in Bhutan, with higher number in the winter 
and spring months (Figure 2). This may be associated with increased dog bite incidents and also mass 
exposure (likely category I exposure) to rabies outbreaks occurring during these seasons. A previous 
study revealed a significantly higher number of rabies cases in animals during late winter through to the 
summer months in Bhutan (based on data from 1996 to 2009) (Tenzin et al., 2011), and it is likely that 
more PEP would have been given during these months. However, PEP data from 1996 to 2004 were not 
analyzed (data not available) to determine if a correlation exists between the number of PEP events and 
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the seasons. A trend in PEP administration is evident, with the number of cases increasing from <1000 in 
the year 2005 to >2800 cases in 2008. This suggests that the number of PEP events is associated with the 
increased incidence of rabies outbreaks and also dog bite incidents (BBS, 2010; Kuensel, 2007). For 
instance, mass anti-rabies vaccination of people (n > 900) was implemented at the time of a major 
rabies outbreak in eastern Bhutan from 2005 to 2007 (Tenzin et al., 2010a) and in south-west Bhutan (n 
> 600) during 2008 (Tenzin et al., 2010b), following contact with rabid animals (likely category I 
exposure) or ingestion of meat and dairy products derived from rabid animals resulting in increased post 
exposure treatment over this period. Similarly, other studies in the US have observed more post 
exposure treatment during summer or warmer months, which is usually associated with increased 
animal exposure (e.g. dog bite) (Helmick 1983; Blanton et al., 2005; Wyatt et al., 1999; O’Bell et al., 
2006).. 
 
Although the recommended PEP regimen may differ based on the category of exposures and the prior 
history of immunization (WHO, 2010a), we found no reports of rabies immunoglobulin being regularly 
administered to dog bite victims in Bhutan. This may be due to the high cost of the biological and limited 
supply in the market (Warrell 2004; Wilde et al., 2005; WHO, 2010a). Although many lives may have 
been saved by using rabies vaccine alone, there are published reports of PEP failures in the absence of 
rabies immunoglobulin and when PEP administration methods had deviated from recommended PEP 
protocols (Shill  et al., 1987; Wilde et al., 1989; WHO, 1995; Wilde  et al., 1996; Gacouin et al., 1999; 
Sriaroon et al., 2003; Matha and Salunke 2005; Wilde 2007; Rupprecht et al., 2009) or occurred as true 
failure even when correct post exposure treatment protocol have been followed (Hemachudha et al., 
1999; Wilde et al., 2005; Shantavasinkul et al., 2010). Considering the prevalence of rabies in domestic 
dogs in the border towns of southern Bhutan, it is imperative that the human rabies immunoglobulin 
(HRIG) (or less expensive equine rabies immunoglobulin (ERIG) or F(ab)2 products of equine rabies 
immunoglobulin) (Quiambao et al., 2008) be administered to proven rabid dog bite cases (WHO 
category III exposure) in southern Bhutan, along with rabies vaccine and proper wound treatment 
(WHO, 2010a). 
 
The rabies post exposure treatment is a complex decision making process for clinicians, especially in a 
country where there are large numbers of stray and free-roaming dogs, when the biting animal is not 
available for observation, where no quarantine of biting animals is practiced and laboratory testing is 
not normally done (McCombie 1989 ; Sriaroon et al., 2005) 
 
Our study indicates that a large amount of rabies PEP is administered to patients whose risk of exposure 
to rabies virus is low (or non-existent) based on the WHO guidelines for post exposures prophylaxis  
(WHO, 2010a). It is also likely that the majority of people who were administered PEP for dog bites may 
in fact have been bitten by normal healthy dogs/pet dogs, and the anti-rabies vaccine may have been 
provided as a precautionary measure either due to pressure from the victims or the physician on duty 
cannot take the risk (Kuensel 2007; McCombie, 1989). We also found that approximately 16% of PEP 
was given to people with non-bite incidents, including touching and feeding of suspected/confirmed 
rabid animals, and ingestion of meat and dairy products (milk, butter, cheese) derived from suspected or 
confirmed rabid cattle. As per the WHO guidelines (WHO, 2010a), this entire group falls under category I 
exposure and no treatment is required. WHO guidelines clearly state that ingestion of raw meat or other 
tissues from animals infected with rabies is not a source of human infection (WHO, 2010a; 2010b). 
Although there have been no well-documented reports of human rabies transmission through such non-
bite incidents (WHO, 2010a; Warrell 2004; ProMED-mail 2010), we believe that the PEP may have been 
administered by the clinician on duty because of the heightened concerns and anxiety of the people 
rather than in response to a true exposure (Blanton et al., 2005; McCombie 1989; Kuensel 2010b). For 
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instance, recently, the death of a suspected rabid cow in one of the villages in southern Bhutan caused 
panic among the people after milk from the cow was consumed, but it was not laboratory examined and 
confirmed due to logistic reason. This resulted in increased demand for post exposure anti-rabies 
vaccination of more than 200 people (Kuensel 2010b). Similar incidents have occurred in Bhutan during 
previous outbreaks, requiring mass post exposure vaccination of people (normally category I exposure) 
(Kuensel 2009b; Tenzin et al., 2010a; Tenzin et al., 2010b). Therefore, following WHO recommendations, 
based on the category of exposure and the epidemiological likelihood of the implicated animal being 
rabid to make a decision about PEP would avoid unnecessary PEP and reduce the expenditure (WHO, 
2010a). 
 
Furthermore, our study also shows that 43 people were given rabies PEP following rat bites (Table 9.1). 
Rat rabies is a rare phenomenon and may represent only incidental infection of rats by dog or cat 
attacks or by eating infected dog or cat carrion (Sriaroon et al., 2005; Kamoltham et al., 2002). House 
rats and mice (and rodent species in general) are not a natural reservoir of rabies and post exposure 
prophylaxis is seldom indicated for rat bites (Sriaroon et al., 2005; Corey and Hattwick 1975). In addition, 
several field studies in other countries have not recovered rabies virus from sampled rats (Sriaroon et 
al., 2005; Kantakamalakul et al., 2003; Patabendige et al., 2003; Wincewicz 2002).   
 
Unlike other vaccines, PEP for rabies requires repeated visits by the patient to the hospital to complete a 
full course within 28 days (e.g. Essen regimen). Therefore, patient compliance is important for adequate 
immunization (Madhusudhana et al., 2002). Our analysis shows that about 40% of patients received an 
incomplete vaccine course (<5-dose course) between 2005 and 2008. Analysis of the dataset shows that 
patients presenting to hospitals in rabies risk areas (rabies outbreak or endemic area) were less likely to 
have an incomplete course of the vaccine. Among the incomplete recipients of vaccine, almost half of 
the patients were from the interior of Bhutan where the risk of infection – even if they were left 
untreated – was low or non-existent since there have been no reported rabies cases in dogs in the 
interior of Bhutan for at least 18 years (Tenzin et al., 2010a). Similarly, animal bite victims are less likely 
to have an incomplete course than non-bite exposures (which pose less risk of infection). One study in 
Thailand (Sriaroon et al., 2005) have shown that almost one-third of the dog bite patients neglected to 
come for the last dose (day 90) of the vaccine series (Thai Red Cross ID regimen) and did not complete a 
full vaccine series. Asian Rabies Expert Bureau (AREB) members emphasized the need for a simplified 
PEP protocols-requiring reduced number of clinic visits (Dodet, 2010). The shortening of time to 
complete the PEP vaccination schedule would help in increasing the patient compliance for completion 
of the PEP course and also would reduce the burden on patients, in terms of loss of time for work and 
transportation cost (Dodet, 2010; Shantavasinkul et al., 2010). However, research is ongoing to develop 
shorter schedules of PEP regimen. For example, most recently, a reduced dose rate – 1ml dose each on 
day 0, 3, 7, 14 (4 intramuscular injection) that complete the course within two weeks was introduced 
and recommended by US-CDC (Rupprecht et al., 2009; Rupprecht et al., 2010), and even shorter 
schedule “one week, 4-site” (4-site intradermal injections on day 0, 3 and 7), developed by the Thai Red 
Cross and the Queen Saovabha Memorial Hospital in Bangkok, Thailand (based on their preliminary 
findings) have shown a significantly (P < 0.001) higher geometric mean titer of rabies neutralizing 
antibodies on days 14 and 28 than the WHO approved Thai Red Cross (TRC) ID regimen (2-site ID 
injections on each days 0, 3, 7, and 28) (Shantavasinkul et al., 2010; Warrell et al., 2008) . 
 
Post exposure treatments are provided free of charge, resulting in substantial cost to the primary health 
care system in Bhutan. For instance, the government spent about Bhutanese ngultrum (Nu.) one million 
for rabies vaccine from 2002 to 2005 and the expenditure increased to Nu.5.878 million in 2006 (Nu.45 = 
1 US$) (Kuensel 2007). Similarly, it has been estimated that post exposure treatment (rabies vaccine) in 
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humans accounted for most of the cost during the time of rabies outbreak in Bhutan (Tenzin et al., 
2010b). Although WHO guide lines do not recommend PEP for category I exposure (WHO, 2010a), PEP is 
still being provided in Bhutan for these categories of exposures. If rabies vaccine injection is at all 
necessary and demanded by the people (BBS, 2010; McCombie 1989) (in situations such as ingestion of 
cooked meat and dairy products derived from a rabies suspected or confirmed animal), we recommend 
that intra-dermal regimens be considered for these category of exposure and can reduce the cost of 
treatment by about 70%, compared to conventional intramuscular regimens (Khawplod et al., 2006; 
Wilde et al., 1999). The intra-dermal regimes have been successfully used in many rabies endemic 
countries in Asia – including Thailand, Sri Lanka, The Philippines, and India – and have been found to be 
equally immunogenic and as effective as that of the standard intramuscular regimen (WHO, 1996; 
Madhusudhana et al., 2002; Khawplod et al., 2006; Wilde et al., 1999; Brown et al., 2008; Brown et al., 
2011). 
  
Finally, the overall goal of public health policy should be to reduce post exposure treatment in humans 
by conducting proper risk assessment, public awareness education programs and by increasing 
vaccination coverage in dogs (WHO, 2010a). Mass vaccination of dogs have been documented to be a 
more beneficial, less expensive, logical and ethical way to control rabies in animals than mass post 
exposure treatment of people alone in resource-limited countries (Bodel and Meslin 1990; Zinsstag et 
al., 2007; Kayali et al., 2006). A One-Health approach should be encouraged and strengthened by 
collaboration and pooling of resources between public health and veterinary services for rabies control 
program in Bhutan. Sharing of information about the local epidemiology of rabies in animals between 
animal and human professionals can help the clinician to make appropriate decisions for post exposure 
treatment in Bhutan. A thorough assessment of each individual case by following the WHO guidelines 
and decision making pathway algorithm (a flow-chart with a decision-making tree) (Corey and Hattwick 
1975; Moran et al., 2000; Rupprecht and Gibbons 2004; Dubnov et al., 2006; WHO, 2010a; Dodet, 2010) 
would reduce the overuse or misuse of the post exposure treatment, and therefore reduce expenditure 
in Bhutan. We also recommend improving the country-wide PEP rabies surveillance system in hospitals 
and Basic Health Units by updating the database management and reporting system. This would provide 
a means to assess the expenditure and status of the rabies control program. 
 
Acknowledgements 
 
The authors wish to thank the staff of the medical hospitals and BHUs in Bhutan for their help in 
providing access to the PEP record. Thanks to the livestock staff for their valued help in collection of the 
data. 
 
Conflict of interest statement: There was no conflict of interest. 
 
 
References 
 
1. Knobel DL, Cleaveland S, Coleman PG, Fèvre EM, Meltzer MI, Miranda MEG,et al. Re-evaluating 
the burden of rabies in Africa and Asia. Bull World Health Organ 2005;83(5):360–8. 
2. World Health Organization. Rabies vaccines: WHO position paper. Wkly Epidemiol Rec 
2010;85(32):309–20. 
3. World Health Organization. Recommendations on rabies post-exposure treatment and the 
correct technique of intradermal immunization against rabies. No. 21. WHO/EMS/ZOO 966. 
Geneva: WHO; 1996. 
14 
 
 
4. Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet 2004;363:959–69. 
5. Tenzin, Dhand NK, Ward MP. Patterns of rabies occurrence in Bhutan between 1996 and 2009. 
Zoonoses Public Health 2011 doi:101111/j1863-2378201101393x2011 [Published online 15 
February 2011]. 
6. Ministry of Health. Annual Health Bulletin 2010. Available at: 
http://www.health.gov.bt/ahb2010.php [accessed January 20, 2010]. 
7. Kuensel. Second rabies fatality in Gelephu. Available 
at:http://www.kuenselonline.com/modules.php?name=News&file=article&sid=13070 [accessed 
July 27, 2009]. 
8. Kuensel. Boy with rabies in JDWNRH. Available 
at:http://www.kuenselonline.com/modules.php?name=News&file=article&sid=15185 [accessed 
April 14, 2010]. 
9. Bhutan Broadcasting Service. Man dies from rabies. Available 
at:http://www.bbs.com.bt/bbs/?p=3519 [accessed January 26, 2011]. 
10. Bhutan Broadcasting Service. Panicked residents rush for antirabies vaccination. Available at: 
http://www.bbs.com.bt/Panicked%20residents%20rush%20for%20anti-
rabies%20vaccination.html [accessed August 31, 2010]. 
11. Bhutan Observer. Who lets the dog out? Available 
at:http://www.bhutanobserver.bt/2008/bhutan-news/04/who-let-the-dogout.html [accessed 
November 20, 2010]. 
12. Kuensel. Rabies outbreak in Nganglam, Available at: 
http://www.kuenselonline.com/modules.php?name=News&file=print&sid=13051[accessed July 
24, 2009]. 
13. National Statistical Bureau. Results of the population and housing census of Bhutan 2005. 
Available at: http://www.nsb.gov.bt/pub/phcb/PHCB2005.pdf[accessed January 19, 2011]. 
14. Dohoo I, Martin W, Stryhn H. Veterinary epidemiologic research. 2nd ed. Charlottetown,Prince 
Edward Island, Canada: VER Inc.; 2009. 
15. Martin RJ, Schnurrenberger PR, Rose NJ. Epidemiology of rabies vaccinations of persons in 
Illinois 1967–68. Public Health Rep 1969;84(12):1069–77. 
16. Helmick CG. The epidemiology of human rabies postexposure prophylaxis,1980–1981. JAMA 
1983;250(15):1990–6. 
17. Pancharoen C, Thisyakorn, Lawtongkum W, Wilde H. Rabies exposures in Thai children. 
Wilderness Environ Med 2001;12:239–43. 
18. Sriaroon C, Sriaroon P, Daviratanasilpa S, Khawplod P, Wilde H, Retrospective:.animal attacks 
and rabies exposures in Thai children. Trav Med Infect Dis 2006;4:270–4. 
19. Blanton JD, Bowden NY, Eidson M, Wyatt JD, Hanlon CA. Rabies postexposure prophylaxis, New 
York, 1995–2000. Emerg Infect Dis 2005;11(12):1921–7. 
20. Edison M, Bingman AK. Terestrial rabies and human postexposure prophylaxis, New York, USA. 
Emerg Infect Dis 2010;16(3):1527–9. 
21. Wyatt JD, Barker WH, Bennett NM, Hanlon CA. Human rabies postexposure prophylaxis during a 
raccoon rabies epizootic in New York, 1993 and 1994. Emerg Infect Dis 1999;5(3):415–23. 
22. Dodet B, Asian Rabies Expert Bureau. Report of the sixth AREB meeting, Manila, The Philippines, 
10–12 November 2009: conference report. Vaccine 2010;28:3265–8. 
23. Khokhar A, Meena GS, Mehra M. Profile of dog bites cases attending M.C.D. dispensary at 
Alipur, Delhi. Ind J Comm Med 2003;28(4):157–60. 
24. O’Bell SA, McQuiston J, Bell LJ, Ferguson SC, Williams LA. Human rabies exposures and 
postexposure prophylaxis in South Carolina, 1993–2002. Public Health Rep 2006;121:197–202. 
15 
 
25. Kuensel. Stray free by December 2007, Kuensel news. Available 
at:http://www.kuenselonline.com/modules.php?name=News&file=article&sid=8623) [accessed 
November 27, 2010]. 
26. Tenzin, Dhand NK, Dorjee J, Ward MP. Re-emergence of rabies in dogs and other domestic 
animal in eastern Bhutan, 2005–2007. Epidemiol Infect 2010;139:220–5. 
27. Tenzin, Sharma B, Dhand NK, Timsina N, Ward MP. Reemergence of rabies in Chhukha district, 
Bhutan, 2008. Emerg Infect Dis 2010;16(12):1925–9. 
28. Wilde H, Khawplod P, Khamoltham T, Hemachudha T, Tepsumethanon V, Lumlerdacha B, et al. 
Rabies control in South and Southeast Asia. Vaccine 2005;23:2284–9. 
29. Gacouin AH, Bourhy JC, Renaud CC, Suprin RT. Human rabies despite postexposure vaccination. 
Eur J Clin Microbiol Infect Dis 1999;18:233–5. 
30. Wilde H, Choomkasient P, Hemachudha T, Supich C, Chutivongse S. Failure of rabies 
postexposure treatment in Thailand. Vaccine 1989;7:49–52. 
31. Wilde H, Sirikawin S, Sabcharoen A, Kingnate D, Tantawichien T, Harischandra PAL, et al. Failure 
of postexposure treatment of rabies in children. Clin Infect Dis 1996;22:228–32. 
32. Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, et al. Evidence for a 4-dose 
vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated 
individuals. Vaccine 2009;27:7141–8. 
33. Shill M, Baynes RD, Miller SD. Fatal rabies encephalitis despite appropriate postexposure 
prophylaxis. N Engl J Med 1987;316:1257–8. 
34. World Health Organization. Report of a WHO consultation on intradermal application of human 
rabies vaccine. Geneva: WHO; 1995. 
35. Wilde H. Failures of post-exposure rabies prophylaxis. Vaccine 2007;25:7605–9. 
36. Matha IS, Salunke SR. Immunogenicity of purified Vero Cell rabies vaccine used in the treatment 
of fox-bite victims in India. Clin Infect Dis 2005;40:611–3. 
37. Sriaroon C, Daviratanasilpa S, Sansomranjai P, Khawplod P, Hemachudha T, Khamoltham T, et al. 
Rabies in a Thai child treated with the eight-site post-exposure regimen without rabies immune 
globulin. Vaccine 2003;21:3525–6. 
38. Shantavasinkul P, Tantawichien T, Wacharapluesadee S, Jeamanukoolkit A, Udomchaisakul P, 
Chattranukulchai P, et al. Failure of rabies postexposure prophylaxis in patients presenting with 
unusual manifestations. Clin Infect Dis 2010;50:77–9. 
39. HemachudhaT, Mitrabhakdi E, Wilde H, Vejabhuti A, Siripataravanit S, Kingnate D. Additional 
reports of failure to respond to treatment after rabies exposure in Thailand. Clin Infect Dis 
1999;28:143–4. 
40. Quiambao BP, DyTioco HZ, Dizon RM, Crisostomo ME, Laot TM, Teuwen DE. Rabies post-
exposure prophylaxis in the Philippines: health status of patients having received purified equine 
F(ab_)2 fragment rabies immunoglobulin (Favirab). PLoS Negl Trop Dis 2008;2(5):e243, 
doi:10.1371/journal.pntd.0000243. 
41. McCombie SC. The politics of immunization in public health. Soc Sci Med 1989;28(8):843–9. 
42. Sriaroon C, Jaijaroensup W, Tantawichien T, Benjawongkunchai M, Supich C, Wilde H. Common 
dilemmas in managing rabies exposed subjects. Trav Med Infect Dis 2005;3:1–7. 
43. World Health Organization. Guide for post-exposure prophylaxis. Available at: 
http://www.who.int/rabies/human/postexp/en/ [accessed March 22, 2011]. 
44. World Health Organization. Rabies: Fact Sheet No. 99 – Updated September 2010. Available at: 
http://www.who.int/mediacentre/factsheets/fs099/en/ [accessed March 22, 2011]. 
45. Promed. Rabies, bovine – Bhutan: milk infectivity debated. Available at: 
http://www.cdc.gov/rabies/resources/news/2005-12-23.html [accessed September 2, 2010]. 
16 
 
46. Kuensel. Death of rabid cow sparks panic. Available at: 
http://www.kuenselonline.com/2010/modules.php?name=News&file=article&sid=16550 
[Accessed August 28, 2010]. 
47. Kamoltham T, Tepsumethanon V, Wilde H. Rat rabies in Phetchabun province,Thailand. J Travel 
Med 2002;9:106–7. 
48. Corey L, Hattwick MAW. Treatment of persons exposed to rabies. JAMA 1975;232(3):271–6. 
49. Kantakamalakul W, Siritantikorn S, Thongcharoen P, Singchai C, Puthavathana P. Prevalence of 
rabies virus and Hantaan virus infections in commensal rodents and shrews trapped in Bangkok. 
J Med Assoc Thai 2003;86(11):1008–14. 
50. Patabendige CG, Wimalaratne O. Rabies in mongooses and domestic rats in the southern 
province of Sri Lanka. Ceylon Med J 2003;48(2):48–50. 
51. Wincewicz E. Microbiological examination of wild rats living in various environments in the 
epizootic aspects EJPAU, vol. 5, no. 1; 2002. Available at: 
http://www.ejpau.media.pl/volume5/issue1/veterinary/art-04.html [accessed December 2, 
2011]. 
52. MadhusudanaSN,AnandNP, Shamsundar R. Economical multi-site intradermal regimen with 
purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid 
animals. Int J Infect Dis 2002;6:210–4. 
53. Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N, et al. 
Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis 
2010;50:56–60. 
54. Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, et al. Use of a reduced (4-dose) 
vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of 
the advisory committee on immunization practices. MMWR 2010;59. 
55. Khawplod P, Wilde H, Sirikwin S, Benjawongkulchai M, Limusanno S, Jaijaroensab W, et al. 
Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-
day booster injection. Vaccine 2006;24:3084–6. 
56. Wilde H, Tipkong P, Khawplod P. Economic issues in postexposure rabies treatment. J Travel 
Med 1999;6:238–42. 
57. Bogel K, Meslin FX. Economics of human and canine rabies elimination: guidelines for 
programme orientation. Bull World Health Organ 1990;68(3):281–91. 
58. Zinsstag J, Schelling E, Roth F, Bonfoh B, Savigny Dd, Tanner M. Human benefits of animal 
interventions for zoonosis control. Emerg Infect Dis 2007;13(4):527–31. 
59. Kayali U, Mindekem R, Hutton G, Ndoutamia AG, Zinsstag J. Cost-description of a pilot 
parenteral vaccination campaign against rabies in dogs in N’Djaména, Chad. Trop Med Int Health 
2006;11:1058–65. 
60. Dubnov J, Hefer E, Rubin L, Rishpon S. A change in rabies post-exposure treatment guidelines 
after decision analysis in Israel. Eur J Public Health 2006;17(1):92–7. 
61. Moran GJ, Talan DA, Mower W, Newdow M, Ong S, Nakase JY, et al. Appropriateness of rabies 
postexposure prophylaxis treatment for animal exposures. JAMA 2000;284(8):1001–7. 
62. Rupprecht CE, Gibbons RV. Prophylaxis against rabies. N Engl J Med 2004;351:2626–35. 
 
 
 
 
